Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0000315066-15-003185
Filing Date
2015-10-21
Accepted
2015-10-21 18:29:42
Documents
2
Period of Report
2015-10-21

Document Format Files

Seq Description Document Type Size
1 PRIMARY DOCUMENT primary_doc.html 3  
1 PRIMARY DOCUMENT primary_doc.xml 3 6622
2 EX-24 DOCUMENT attachment1.txt EX-24 3810
  Complete submission text file 0000315066-15-003185.txt   12033
Mailing Address 245 SUMMER STREET BOSTON MA 02210
Business Address 245 SUMMER STREET BOSTON MA 02210 6175706339
FMR LLC (Reporting) CIK: 0000315066 (see all company filings)

Fiscal Year End: 1231
Type: 3 | Act: 34 | File No.: 001-37601 | Film No.: 151168839

Mailing Address 840 MEMORIAL DRIVE 4TH FLOOR CAMBRIDGE MA 02139
Business Address 840 MEMORIAL DRIVE 4TH FLOOR CAMBRIDGE MA 02139 617-401-0011
Dimension Therapeutics, Inc. (Issuer) CIK: 0001592288 (see all company filings)

EIN.: 463942159 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2836 Biological Products, (No Diagnostic Substances)